EM Command Center / Neurology & Psychiatry • 3 min read • 6 sections

Status Epilepticus & Refractory Seizures

Evidence-based, time-critical management of status epilepticus based on American Epilepsy Society (AES) guidelines. Features rapid phase-1 benzodiazepine dosing, phase-2 non-sedating AED selection (levetiracetam, fosphenytoin, valproate), and phase-3 continuous infusion anesthetic induction.

Resuscitation Quick Ribbon (First 2 Minutes)

High-Acuity

t = 0-5 min:ABCs, fingerstick glucose, high-flow O2, capnography, IV access, and ECG.

t = 5-10 min (Phase 1):Full-dose IV lorazepam 4 mg (0.1 mg/kg) or IM midazolam 10 mg (>40 kg). Repeat once at 5-10 min if seizing continues.

t = 10-20 min (Phase 2):Non-sedating IV AED immediately without waiting for second benzo to fail: Levetiracetam 60 mg/kg (max 4.5 g) OR Fosphenytoin 20 mg PE/kg (max 1.5 g PE) OR Valproate 40 mg/kg (max 3 g).

t = 20-40 min (Phase 3 / Refractory):Propofol (2-5 mg/kg bolus, 50-100 mcg/kg/min) or Midazolam (0.2 mg/kg bolus, 0.05-2 mg/kg/hr) infusion + RSI endotracheal intubation.

Special etiologies:Eclampsia -> Magnesium sulfate 4-6 g IV; Isoniazid/B6 deficiency -> Pyridoxine 5 g IV; Hypoglycemia -> D50W 50 mL IV; Hyponatremia -> 3% NaCl 100-150 mL IV.

Bottom-Line Clinical Pearl

Underdosing benzodiazepines is the #1 preventable cause of treatment failure in status epilepticus. Administer adequate full-dose IV lorazepam (0.1 mg/kg, max 4 mg) or IM midazolam (10 mg for >40 kg) promptly at t=5 minutes.

1. Operational Definitions & Pathophysiologic Timeline

Status epilepticus is defined by the International League Against Epilepsy (ILAE) by two critical time points (t1 and t2):

Time Point	Generalized Convulsive SE	Focal SE with Impaired Awareness	Clinical Implication
t1 (Start Treatment)	5 minutes of continuous seizure OR >= 2 seizures without recovery	10 minutes of seizure activity	Seizures lasting beyond t1 are unlikely to stop spontaneously; initiate Phase 1 pharmacotherapy immediately.
t2 (Neuronal Injury)	30 minutes of continuous seizure activity	>= 60 minutes	Irreversible neuronal necrosis, pharmacoresistance due to GABA receptor internalization, and blood-brain barrier breakdown occur.

2. Phase-Based Treatment Protocol (AES Guidelines)

The American Epilepsy Society and Neurocritical Care Society consensus protocol mandates strict adherence to time intervals to prevent pharmacoresistance:

Phase & Time	Primary Medications & Exact Dosing	Second-Line / Alternative Option	Key Pharmacologic Caveats
Phase 1 (5-10 min) Emergent Initial	Lorazepam 0.1 mg/kg IV (max 4 mg single dose; push over 2 min) OR Midazolam 10 mg IM (if weight > 40 kg; 5 mg if 13-40 kg)	Diazepam 0.15-0.2 mg/kg IV (max 10 mg); Rectal Diazepam 0.2-0.5 mg/kg if no IV/IM access	IM Midazolam is superior to IV Lorazepam in prehospital/no-IV setting due to rapid absorption and zero delay in vascular access.
Phase 2 (10-30 min) Urgent Control	Levetiracetam 60 mg/kg IV (max 4500 mg, infuse over 10 min) OR Fosphenytoin 20 mg PE/kg IV (max 1500 mg PE, rate <= 150 mg PE/min)	Valproate sodium 40 mg/kg IV (max 3000 mg over 10 min); Alternative: Lacosamide 400 mg IV over 5 min	The ESETT trial demonstrated equivalent efficacy (~47% termination) between Levetiracetam, Fosphenytoin, and Valproate. Choose based on organ function/contraindications.
Phase 3 (30-60 min) Refractory SE	Propofol: 2-3 mg/kg IV bolus, then 50-100 mcg/kg/min infusion OR Midazolam: 0.2 mg/kg IV bolus, then 0.1-2 mg/kg/hr infusion	Ketamine: 1.5-3 mg/kg IV bolus, then 1-5 mg/kg/hr infusion; Pentobarbital: 5 mg/kg bolus, then 1-5 mg/kg/hr	Requires endotracheal intubation. Continuous EEG monitoring is mandatory to titrate to burst suppression or seizure cessation.

Clinical Caution

Phase 2 Selection Pearls: Fosphenytoin requires cardiac telemetry due to risk of hypotension and QTc prolongation; avoid in known structural heart disease or AV block. Valproate is contraindicated in hepatic failure, acute pancreatitis, and mitochondrial disorders. Levetiracetam has the cleanest cardiovascular and drug-interaction safety profile.

3. Immediate Etiologic Workup & Reversible Triggers

Point-of-Care Glucose: Check immediately. If < 60 mg/dL, give D50W 50 mL IV (adults) or D10W 5 mL/kg IV (pediatrics). Add Thiamine 100 mg IV before glucose in suspected alcohol use disorder.
Electrolytes: Hyponatremia (< 120 mEq/L) causing seizures requires 3% Hypertonic Saline: 100-150 mL IV bolus over 10-15 minutes (repeat up to twice to increase serum sodium by 4-6 mEq/L).
Pregnancy (> 20 weeks up to 6 weeks postpartum): Eclampsia until proven otherwise. Administer Magnesium Sulfate 4-6 g IV bolus over 15-20 min, then 1-2 g/hr infusion. Benzodiazepines and phenytoin are second-line in eclampsia.
Toxic Ingestions & Antidote Triggers: Isoniazid (give Pyridoxine 5 g IV for unknown amount, or gram-for-gram); Tricyclic antidepressants (Sodium bicarbonate 1-2 mEq/kg IV); Organophosphates (Atropine + Pralidoxime); Theophylline / Bupropion (early hemodialysis).
Subtherapeutic AED Levels: Obtain serum levels of phenytoin, carbamazepine, valproic acid, and levetiracetam in patients with known epilepsy.

4. Nonconvulsive Status Epilepticus (NCSE)

Up to 20-30% of patients following successful cessation of motor convulsive status remain in nonconvulsive status epilepticus. Suspect NCSE when:

The patient fails to regain baseline mental status or awaken within 20-30 minutes after convulsions cease.
Subtle motor signs: Rhythmic eye fluttering, nystagmoid jerking, twitching of facial muscles, fingers, or toes.
Persistent autonomic instability: Tachycardia, hypertension, diaphoresis, hyperthermia despite absence of major motor movement.
Diagnostic Action: Stat continuous EEG (cEEG) and urgent neurology consult. Do not wait for awakening if EEG confirms ongoing electrographic status; escalate to Phase 2/Phase 3 AEDs.

5. Airway & RSI in Refractory Status

Critical Pitfall / Contraindication

Neuromuscular Blocker Selection in SE: Rocuronium (1.2 mg/kg IV) or high-dose Vecuronium is preferred over Succinylcholine if rhabdomyolysis or severe hyperkalemia is suspected from prolonged convulsions. CRITICAL: Paralyzing the patient stops motor movements but DOES NOT STOP electrographic brain seizures. Always pair paralytics with continuous IV anesthetics (propofol/midazolam) and EEG.

6. Attending Disposition & Post-Resuscitation Care

ICU Admission: All patients receiving Phase 2 or Phase 3 medications, patients requiring intubation, or those with prolonged post-ictal depression requiring continuous EEG monitoring.
Neuroimaging: Non-contrast head CT mandatory for first-time seizure, persistent altered mental status, focal deficit, trauma, or signs of elevated ICP. Follow with MRI brain inpatient.
Lumbar Puncture: Perform if fever, immunocompromise, meningismus, or unexplained new-onset status epilepticus (after ruling out space-occupying lesion with CT).
Rhabdomyolysis & AKI Monitoring: Check serum CK, creatinine, and urine myoglobin. Initiate aggressive IV crystalloid hydration if CK > 5000 IU/L to prevent acute tubular necrosis.

Board & Shelf Drill 5 Questions • Untimed Tutor Mode

Test Your Status Epilepticus & Refractory Seizures Clinical Acumen

Directly launch an active-recall practice block from our 8,400+ validated COMLEX Level 1, 2-CE & 3 board question bank with complete explanations.

Related Emergency Protocols & Differentials

Related EM Protocol